Nippon Kayaku Co., Ltd. (4272.T) JPX

2,082.50

-33(-1.56%)

Updated at June 02 03:30PM

Currency In JPY

Nippon Kayaku Co., Ltd.

Address

Meiji Yasuda Seimei Building

Tokyo, 100-0005

Japan

Phone

81 3 6731 5200

Sector

Basic Materials

Industry

Chemicals

Employees

5902

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Shigeyuki KawamuraPresident, Chief Executive Officer & Director01963
Hideyuki YuyaMD & Head of Polatechno Group0N/A
Yoshiki AkataniManaging Director of Fine Chemicals Business Area0N/A
Hiroshi ShimadaSenior MD, Head of Pharmaceuticals Group & Director01965
Ichio KohinataGeneral Manager of Legal Affairs Division0N/A
Tsutomu KawamuraGeneral Manager of Finance & Accounting Division0N/A
Seiichiro KodamaHead of Agrochemicals Group of Life Science Business Unit0N/A
Shinji InoueSenior Executive Officer of planning, Corporation Communication & Accounting and Director01966
Yasuhito KatoMD of Technology & Director01965
Makoto TakedaMD of Human Resource & Director01964
Shigehide KagayaHead of Catalysts Group, Fine Chemicals Business Unit0N/A

Description

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.